As a doctoral student at Yale University, John Rinn began groundbreaking research in the field of genetics. Following the discovery of a type of RNA known as LINC (large intervening non-coding RNA), John Rinn continued his research as a professor at Harvard University until 2017, when he accepted the Marvin H. Caruthers Endowed Chair for Early-Career Faculty at the BioFrontiers Institute at the University of Colorado Boulder, where he also serves as the Leslie Orgel Professor of RNA Science.
Headed by Nobel Prize recipient Thomas Cech, the BioFrontiers Institute operates under the umbrella of the University of Colorado Boulder. It focuses particularly on cutting-edge research efforts, drawing innovative minds from around the world.
In order to create an environment for its pioneering research, the BioFrontiers Institute encompasses experienced faculty members from a diverse range of academic backgrounds. By bringing together researchers in physical and life sciences as well as professionals in engineering and computer science, the institute encourages exciting collaboration in areas such as genome exploration.
As a HHMI early career scientist, John Rinn dedicates his research to RNA biology. Specifically, focusing on how long noncoding RNA (lncRNA) genes can play important biological roles as RNA molecules (rather than the more commonly studied protein based genes). John Rinn teaches courses at the University of Colorado Boulder as the Leslie Orgel Professor of RNA Science. Outside his basic research, John Rinn also serves on the editorial board of Genome Biology, a leading peer-reviewed, open-access scientific journal.
Genome Biology is committed to publishing exceptional research in all areas of biomedicine and biology studied through a post-genomic and genomic lens. For its work, Thomson Reuters listed Genome Biology the fourth-ranked journal in terms of impact in the Genetics and Heredity category. Here are several editorial and publishing practices at Genome Biology that have contributed to its status within the industry.
1. The journal has more than 46,000 followers on its Twitter account and is dedicated to promoting its content both through its social media presence, well-designed homepage, and press releases.
2. Committed to editorial transparency, Genome Biology publishes a peer reviewer report with every article it publishes. (This practice pertains to submissions starting on January 1, 2019.)
3. To better serve authors, reviewers, and readers, the journal maintains high standards of hospitality throughout the publishing process, including proactive communication on the progress of a manuscript.